Centene CorpCNC
▲ PositiveCapitalrelevance
Article states Centene trades at a low P/S ratio and screens as undervalued, suggesting a bargain.
Impact on stocks 1
Health Care
Centene CorpCentene stock has returned 114.2% over the past year, yet valuation checks still lean cheap. The company trades on a price-to-sales ratio of about 0.2 times, well below the healthcare industry average of around 1.5 times and a peer average near 1.7 times. Simply Wall St's fair ratio estimate for Centene is about 0.9 times, suggesting the current multiple sits well below what this tailored yardstick indicates. On Simply Wall St's checks, Centene screens as undervalued in five of six areas, so the broader set of valuation indicators leans cheap rather than fully pricing in the past year's rally. The key question for investors is whether this discount compensates for policy and funding risks tied to state program changes, or whether it reflects an earnings base that the market remains reluctant to reward with a higher multiple.
Centene CorpArticle states Centene trades at a low P/S ratio and screens as undervalued, suggesting a bargain.